Report - Targeted Therapies for Advanced NSCLCimg.medscape.com/images/867/844/867844_slides.pdfSep 15, 2011  · JO25567 Phase II Trial Erlotinib +/- Bevacizumab •Stage IIIB/IV NSCLC •EGFR

Please pass captcha verification before submit form